Qurient Co., Ltd. (KOSDAQ:115180)
South Korea · Delayed Price · Currency is KRW 26,700
-100 (-0.37%)
At close: May 19, 2026
Qurient Revenue
In the year 2025, Qurient had annual revenue of 6.98B KRW, down -23.94%. Qurient had revenue of 1.53B in the quarter ending December 31, 2025, a decrease of -45.82%.
Revenue
6.98B
Revenue Growth
-23.94%
P/S Ratio
152.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.06T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.98B | -2.20B | -23.94% |
| Dec 31, 2024 | 9.18B | 148.03M | 1.64% |
| Dec 31, 2023 | 9.03B | 563.25M | 6.65% |
| Dec 31, 2022 | 8.47B | 3.58B | 73.33% |
| Dec 31, 2021 | 4.89B | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CORESTEMCHEMON | 20.16B |
| JS Link | 19.32B |
| TiumBio | 12.29B |
| Kangstem Biotech | 3.57B |
| Inventage Lab | 2.94B |
| AprilBio | 2.17B |
| Ensol Biosciences | 537.46M |
| ViGenCell | 278.95M |